摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2-amino-5,10,10-trihydroxy-6-imino-9-sulfooxy-3a,4,8,9-tetrahydro-3H-pyrrolo[1,2-c]purin-4-yl)methyl carbamate

中文名称
——
中文别名
——
英文名称
(2-amino-5,10,10-trihydroxy-6-imino-9-sulfooxy-3a,4,8,9-tetrahydro-3H-pyrrolo[1,2-c]purin-4-yl)methyl carbamate
英文别名
——
(2-amino-5,10,10-trihydroxy-6-imino-9-sulfooxy-3a,4,8,9-tetrahydro-3H-pyrrolo[1,2-c]purin-4-yl)methyl carbamate化学式
CAS
——
化学式
C10H17N7O9S
mdl
——
分子量
411.35
InChiKey
CETRDCWBMBILAL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -5.7
  • 重原子数:
    27
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    266
  • 氢给体数:
    8
  • 氢受体数:
    11

上下游信息

反应信息

点击查看最新优质反应信息

文献信息

  • Preparative scale conversion of gonyautoxins to neosaxitoxin
    申请人:THE CAWTHRON INSTITUTE TRUST BOARD
    公开号:US10822344B2
    公开(公告)日:2020-11-03
    A method of preparing neosaxitoxin in quantities of a purity sufficient to allow the compound to be used as an active pharmaceutical ingredient (API) is described. The method includes the reductive desulfonation of an unresolved mixture of gonyautoxin 1 (GTX1) and gonyautoxin 4 (GTX4).
    本文介绍了一种制备新沙西托星的方法,其纯度足以使该化合物用作活性药物成分(API)。该方法包括对贡戈毒素 1(GTX1)和贡戈毒素 4(GTX4)的未还原混合物进行还原脱硫。
  • PREPARATIVE SCALE CONVERSION OF GONYAUTOXINS TO NEOSAXITOXIN
    申请人:THE CAWTHRON INSTITUTE TRUST BOARD
    公开号:US20200255441A1
    公开(公告)日:2020-08-13
    A method of preparing neosaxitoxin in quantities of a purity sufficient to allow the compound to be used as an active pharmaceutical ingredient (API) is described. The method includes the reductive desulfonation of an unresolved mixture of gonyautoxin 1 (GTX1) and gonyautoxin 4 (GTX4).
  • SEMISYNTHETIC METHODS OF PREPARING GTX1,4 AND NEOSAXITOXIN
    申请人:THE CAWTHRON INSTITUTE TRUST BOARD
    公开号:US20210340153A1
    公开(公告)日:2021-11-04
    Semisynthetic methods of preparing neosaxitoxin from cultures of the dinoflagellates Alexandrium pacificum and Gymnodinium catenatum are described. The scalable method includes the reductive desulfonation of an unresolved mixture of gonyautoxin 1 (GTX1) and gonyautoxin 4 (GTX4) using dithiol in a buffered reaction solvent at a pH of about 7.5.
  • [EN] PREPARATION OF NEOSAXITOXIN<br/>[FR] PRÉPARATION DE NÉOSAXITOXINE
    申请人:THE CAWTHRON INST TRUST BOARD
    公开号:WO2021191848A1
    公开(公告)日:2021-09-30
    A semisynthetic method of preparing neosaxitoxin from cultures of the dinoflagellate Gymnodinium catenatum is described. The scalable method includes the reductive desulfonation of an unresolved mixture of toxin C3 and toxin C4 and mild acid hydrolysis of the resulting gonyautoxin 6 (GTX6) to provide the neosaxitoxin.
  • Journal of the Chemical Society, Chemical Communications. 1981, 7, 314-315
    作者:
    DOI:——
    日期:——
查看更多

同类化合物

苯丙腈,b-氟-a-羟基- 膝沟藻毒素4 膝沟藻毒素 VIII 膝沟藻毒素 V 膝沟藻毒素 III 膝沟藻毒素 II 膝沟藻毒素 I 去氨基甲酰石房蛤毒素 原膝沟藻毒素4 二乙酸贝毒素 {2-[(3aS,4R,6Z)-2-氨基-5,10,10-三羟基-6-亚氨基-9-(磺基氧基)-3a,4,5,6-四氢-3H,10H-吡咯并[1,2-c]嘌呤-4-基]-1,1-二羟基乙基}氨基磺酸 (3As,10As)-3Aa,4,9,10-四氢-2,6-二氨基-4a-[[(磺基氨基羰基)氧基]甲基]-1H,8H-吡咯并[1,2-c]嘌呤-9b,10,10-三醇 9-硫酸酯 GTX 3 Atelopidtoxin ((3aS,4R,10aS)-10,10-dihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl)methyl (2-aminoethyl)carbamate (3aS,4R,10S,10aR)-tert-butyl 2,6-bis((tert-butoxycarbonyl)imino)-4-((carbamoyloxy)methyl)-10-hydroxyoctahydropyrrolo[1,2-c]purine-1(8H)-carboxylate [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl N-[2-[3-[2,5-dioxo-3-(9-oxodecyl)pyrrol-1-yl]propanoylamino]ethyl]carbamate [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl N-[2-[3-[2,5-dioxo-3-(9-oxodecyl)pyrrolidin-1-yl]propanoylamino]ethyl]carbamate [2,6-diamino-4-[(1-amino-3-methyl-2-oxo-6-prop-1-en-2-ylcyclohex-3-en-1-yl)oxymethyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-3H-pyrrolo[1,2-c]purin-9-yl] hydrogen sulfate N-Sulfocarbamoylgonyautoxin 2 decarbamoyl-α-saxitoxinol [(3aS,4R,9S,10aS)-2,6-diamino-10,10-dihydroxy-4-(hydroxymethyl)-3a,4,8,9-tetrahydro-3H-pyrrolo[1,2-c]purin-9-yl] hydrogen sulfate ditert-butyl (3aS,4R,10S,10aR)-4-[(4-methoxyphenyl)methoxymethyl]-2,6-bis[(2-methylpropan-2-yl)oxycarbonylimino]-3-methylsulfonyl-10-trimethylsilyloxy-4,8,9,10-tetrahydro-3aH-pyrrolo[1,2-c]purine-1,5-dicarboxylate [(3aS,4R,10S,10aS)-2,6-diamino-10-hydroxy-1,3a,4,8,9,10-hexahydropyrrolo[1,2-c]purin-4-yl]methyl N-(6-aminohexyl)carbamate [(3aS,4R,9S,10R,10aS)-9,10-dihydroxy-6-[(2,2,2-trichloroacetyl)amino]-2-(2,2,2-trichloroethoxysulfonylamino)-1,3a,4,8,9,10-hexahydropyrrolo[1,2-c]purin-4-yl]methyl carbamate (2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methyl N-[6-[4-[4-[2-[4-cyano-5-(dicyanomethylidene)-2,2-dimethylfuran-3-yl]ethenyl]-N-methylanilino]butanoylamino]hexyl]carbamate [(3aR,4R,9R,10aR)-2,6-diamino-10,10-dihydroxy-9-sulfooxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate [(3aS,4R,9R,10aR)-2,6-diamino-10,10-dihydroxy-9-sulfooxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methoxycarbonylsulfamic acid [(3aS,4S,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate [(3aS,4R,9S,10aS)-2,6-diamino-10,10-dihydroxy-4-(hydroxymethyl)-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl] 4-(trifluoromethyl)benzoate 5-[6-[(2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methoxycarbonylamino]hexylcarbamoyl]-2-(2,7-difluoro-3-hydroxy-6-oxoxanthen-9-yl)benzoic acid (2-amino-10,10-dihydroxy-6-pentylimino-1,3a,4,5,8,9-hexahydropyrrolo[1,2-c]purin-4-yl)methyl N-(6-aminohexyl)carbamate (2,6-diamino-1,9,10-trihydroxy-10-methyl-3a,4,8,9-tetrahydropyrrolo[1,2-c]purin-4-yl)methyl N-(3,4-dimethylpentan-2-yl)carbamate (2,6-diamino-1,10-dihydroxy-10-methyl-3a,4,8,9-tetrahydropyrrolo[1,2-c]purin-4-yl)methyl N-[6-[6-(hexylamino)hexanoylamino]hexyl]carbamate (2,6-diamino-1,10-dihydroxy-10-methyl-3a,4,8,9-tetrahydropyrrolo[1,2-c]purin-4-yl)methyl N-[6-[[6-(7-methyloctylamino)-6-oxohexanoyl]amino]hexyl]carbamate Saxitoxin p-bromobenzenesulfonate [(3aS,4R)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate alpha-Saxitoxinol (3aS)-2,6-diamino-4-methyl-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purine-10,10-diol [(3aS,4R,9R,10aS)-2-amino-5,10,10-trihydroxy-4-(hydroxymethyl)-6-imino-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl] hydrogen sulfate [(3aS,4R,9R)-2-amino-5,10,10-trihydroxy-6-imino-9-sulfooxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate (2,6-diamino-1,10-dihydroxy-10-methyl-2,3,3a,4,8,9-hexahydropyrrolo[1,2-c]purin-4-yl)methyl N-propan-2-ylcarbamate (2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methyl N-[4-(2,5-dioxopyrrol-1-yl)phenyl]carbamate (2,6-diamino-1-hydroxy-10-methoxy-4,8,9,10-tetrahydro-3aH-pyrrolo[1,2-c]purin-4-yl)methyl N-propan-2-ylcarbamate (2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methyl N-[[4-[4-(4-methylpentan-2-ylcarbamoyl)benzoyl]phenyl]methyl]carbamate [(4R)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate (2,6-Diamino-1,9,10-trihydroxy-10-methyl-3a,4,8,9-tetrahydropyrrolo[1,2-c]purin-4-yl)methyl carbamate gonyautoxin VI (2,6-diamino-10,10-dihydroxy-5-oxido-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-5-ium-4-yl)methyl carbamate [(3aS,4R,10aS)-2-amino-5,10,10-trihydroxy-6-imino-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate